Literature DB >> 28431814

Evaluation of storing hepatitis B vaccine outside the cold chain in the Solomon Islands: Identifying opportunities and barriers to implementation.

Lucy Breakwell1, Jenniffer Anga2, Ibrahim Dadari3, Nahad Sadr-Azodi4, Divinal Ogaoga2, Minal Patel5.   

Abstract

Monovalent Hepatitis B vaccine (HepB) is heat stable, making it suitable for storage outside cold chain (OCC) at 37°C for 1month. We conducted an OCC project in the Solomon Islands to determine the feasibility of and barriers to national implementation and to evaluate impact on coverage. Healthcare workers at 13 facilities maintained monovalent HepB birth dose (HepB-BD) OCC for up to 28days over 7months. Vaccination data were recorded for children born during the project and those born during 7months before the project. Timely HepB-BD coverage among facility and home births increased from 30% to 68% and from 4% to 24%, respectively. Temperature excursions above 37°C were rare, but vaccine wastage was high and shortages common. Storing HepB OCC can increase HepB-BD coverage in countries with insufficient cold chain capacity or numerous home births. High vaccine wastage and unreliable vaccine supply must be addressed for successful implementation. Published by Elsevier Ltd.

Entities:  

Keywords:  Hepatitis B birth dose; Hepatitis B vaccine; Outside cold chain

Mesh:

Substances:

Year:  2017        PMID: 28431814      PMCID: PMC5893327          DOI: 10.1016/j.vaccine.2017.04.011

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  At-birth immunisation against hepatitis B using a novel pre-filled immunisation device stored outside the cold chain.

Authors:  B F Otto; I M Suarnawa; T Stewart; C Nelson; T A Ruff; A Widjaya; J E Maynard
Journal:  Vaccine       Date:  1999-10-14       Impact factor: 3.641

2.  Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device.

Authors:  A Sutanto; I M Suarnawa; C M Nelson; T Stewart; T I Soewarso
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

3.  Chronic hepatitis B.

Authors:  A S Lok; B J McMahon
Journal:  Hepatology       Date:  2001-12       Impact factor: 17.425

4.  Heat stability of a recombinant DNA hepatitis B vaccine.

Authors:  P Van Damme; M Cramm; A Safary; P Vandepapelière; A Meheus
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

5.  Immunogenicity of a locally produced hepatitis B vaccine with the birth dose stored outside the cold chain in rural Vietnam.

Authors:  David B Hipgrave; Trung Nam Tran; Vu Minh Huong; Do Tuan Dat; Nguyen Tuyet Nga; Hoang Thuy Long; Nguyen Thu Van; James E Maynard; Beverley-Ann Biggs
Journal:  Am J Trop Med Hyg       Date:  2006-02       Impact factor: 2.345

6.  Hepatitis B vaccines.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2009-10-01

7.  Meeting of the Strategic Advisory Group of Experts on immunization, October 2016 –zzm321990conclusions and recommendations.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2016-12-02

8.  Markedly high seroprevalence of hepatitis B virus infection in comparison to hepatitis C virus and human T lymphotropic virus type-1 infections in selected Solomon Islands populations.

Authors:  N Furusyo; J Hayashi; K Kakuda; Y Sawayama; I Ariyama; R Eddie; S Kashiwagi
Journal:  Am J Trop Med Hyg       Date:  1999-07       Impact factor: 2.345

Review 9.  Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors.

Authors:  Giovanna Fattovich; Flavia Bortolotti; Francesco Donato
Journal:  J Hepatol       Date:  2007-12-04       Impact factor: 25.083

10.  Hepatitis B vaccine stored outside the cold chain setting: a pilot study in rural Lao PDR.

Authors:  Amy R Kolwaite; Anonh Xeuatvongsa; Alejandro Ramirez-Gonzalez; Kathleen Wannemuehler; Viengnakhone Vongxay; Vansy Vilayvone; Karen Hennessey; Minal K Patel
Journal:  Vaccine       Date:  2016-03-31       Impact factor: 3.641

View more
  12 in total

1.  Seroprevalence of chronic hepatitis B virus infection and immunity to measles, rubella, tetanus and diphtheria among schoolchildren aged 6-7 years old in the Solomon Islands, 2016.

Authors:  Lucy Breakwell; Jenniffer Anga; Gretchen Cooley; Laura Ropiti; Sarah Gwyn; Kathleen Wannemuehler; Joseph Woodring; Divinal Ogaoga; Diana Martin; Minal Patel; Rania A Tohme
Journal:  Vaccine       Date:  2020-05-28       Impact factor: 3.641

2.  Prevalence of Chronic Hepatitis B Virus Infection among Children in Haiti, 2017.

Authors:  Lana Childs; Paul Adrien; Anna A Minta; Jeannot François; Nadia Phaïmyr Jn Charles; Valery Blot; Gloria Rey-Benito; Jodi L Vanden Eng; Rania A Tohme
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

3.  Hepatitis B vaccine development and implementation.

Authors:  Hong Zhao; Xiaoying Zhou; Yi-Hua Zhou
Journal:  Hum Vaccin Immunother       Date:  2020-03-18       Impact factor: 3.452

Review 4.  Cancer control in the Pacific: big challenges facing small island states.

Authors:  Diana Sarfati; Rachel Dyer; Filipina Amosa-Lei Sam; Michael Barton; Freddie Bray; Eka Buadromo; Alec Ekeroma; Sunia Foliaki; James Fong; Josephine Herman; Linda Huggins; Kiki Maoate; Ineke Meredith; Glen Mola; Neal Palafox; Viliami Puloka; Hai-Rim Shin; Jane Skeen; Wendy Snowdon; Malama Tafuna'i; Andrea Teng; David Watters; Paula Vivili
Journal:  Lancet Oncol       Date:  2019-08-05       Impact factor: 41.316

5.  Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017.

Authors:  Joseph Woodring; Roberta Pastore; Anne Brink; Naoko Ishikawa; Yoshihiro Takashima; Rania A Tohme
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-03-01       Impact factor: 17.586

6.  Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study.

Authors:  Peyton Thompson; Camille E Morgan; Patrick Ngimbi; Kashamuka Mwandagalirwa; Noro L R Ravelomanana; Martine Tabala; Malongo Fathy; Bienvenu Kawende; Jérémie Muwonga; Pacifique Misingi; Charles Mbendi; Christophe Luhata; Ravi Jhaveri; Gavin Cloherty; Didine Kaba; Marcel Yotebieng; Jonathan B Parr
Journal:  Lancet Glob Health       Date:  2021-08-17       Impact factor: 26.763

7.  Mean kinetic temperature evaluations through simulated temperature excursions and risk assessment with oral dosage usage for health programs.

Authors:  David Jenkins; Aida Cancel; Thomas Layloff
Journal:  BMC Public Health       Date:  2022-02-14       Impact factor: 3.295

8.  Countries' interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regions.

Authors:  Dörte Petit; Carole Tevi-Benissan; Joseph Woodring; Karen Hennessey; Anna-Lea Kahn
Journal:  Vaccine       Date:  2017-11-10       Impact factor: 3.641

9.  Cold chain time- and temperature-controlled transport of vaccines: a simulated experimental study.

Authors:  Chun Zheng Ng; Yen Loong Lean; Siang Fei Yeoh; Qi Ying Lean; Kah Seng Lee; Amal Khalil Suleiman; Kai Bin Liew; Yaman Walid Kassab; Yaser Mohammed Al-Worafi; Long Chiau Ming
Journal:  Clin Exp Vaccine Res       Date:  2020-01-31

Review 10.  How the use of vaccines outside the cold chain or in controlled temperature chain contributes to improving immunization coverage in low- and middle-income countries (LMICs): A scoping review of the literature.

Authors:  Ibrahim K Dadari; Janice C Zgibor
Journal:  J Glob Health       Date:  2021-01-31       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.